Literature DB >> 16611408

Whole transcriptome amplification for gene expression profiling and development of molecular archives.

Scott A Tomlins1, Rohit Mehra, Daniel R Rhodes, Rajal B Shah, Mark A Rubin, Eric Bruening, Vladimir Makarov, Arul M Chinnaiyan.   

Abstract

Expression profiling of clinically obtainable tumor specimens has been hindered by the need for microgram quantities of RNA. In vitro transcription (IVT)-based amplifications are most commonly used to amplify small quantities of RNA for microarray analysis. However, significant drawbacks exist with IVT-based amplification, and the need for alternative amplification methods remains. Herein, we validate whole transcriptome amplification (WTA), an exponential amplification technique that produces cDNA libraries and amplified target in 3 to 4 hours from nanogram quantities of total RNA using a combination of cDNA microarrays and quantitative polymerase chain reaction (PCR). We demonstrate that WTA material can serve as a "molecular archive" because a WTA cDNA library can be faithfully amplified through multiple rounds of PCR amplification, allowing it to serve as a bankable and distributable resource. To demonstrate applicability, WTA was combined with laser capture microdissection to profile frozen prostate tissues. Unlike most IVT-based and exponential amplification techniques, WTA does not depend on the presence of a poly-A tail. Thus, we demonstrate that WTA is compatible with artificially degraded RNA and RNA isolated from formalin-fixed paraffin-embedded tissues. Taken together, WTA represents a versatile approach to profile and archive cDNA from minute tumor samples and is compatible with partially degraded RNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611408      PMCID: PMC1578511          DOI: 10.1593/neo.05754

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  28 in total

1.  A PCR-based amplification method retaining the quantitative difference between two complex genomes.

Authors:  G Mike Makrigiorgos; Subrata Chakrabarti; Yuzhi Zhang; Manjit Kaur; Brendan D Price
Journal:  Nat Biotechnol       Date:  2002-08-05       Impact factor: 54.908

2.  RNA amplification results in reproducible microarray data with slight ratio bias.

Authors:  László G Puskás; Agnes Zvara; László Hackler; Paul Van Hummelen
Journal:  Biotechniques       Date:  2002-06       Impact factor: 1.993

3.  Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA.

Authors:  Norman N Iscove; Mary Barbara; Marie Gu; Meredith Gibson; Carolyn Modi; Neil Winegarden
Journal:  Nat Biotechnol       Date:  2002-08-12       Impact factor: 54.908

4.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

5.  Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx.

Authors:  F J Livesey; T Furukawa; M A Steffen; G M Church; C L Cepko
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

6.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

7.  Delineation of prognostic biomarkers in prostate cancer.

Authors:  S M Dhanasekaran; T R Barrette; D Ghosh; R Shah; S Varambally; K Kurachi; K J Pienta; M A Rubin; A M Chinnaiyan
Journal:  Nature       Date:  2001-08-23       Impact factor: 49.962

8.  Rubicon Genomics, Inc.

Authors:  John P Langmore
Journal:  Pharmacogenomics       Date:  2002-07       Impact factor: 2.533

9.  Within the fold: assessing differential expression measures and reproducibility in microarray assays.

Authors:  Ivana V Yang; Emily Chen; Jeremy P Hasseman; Wei Liang; Bryan C Frank; Shuibang Wang; Vasily Sharov; Alexander I Saeed; Joseph White; Jerry Li; Norman H Lee; Timothy J Yeatman; John Quackenbush
Journal:  Genome Biol       Date:  2002-10-24       Impact factor: 13.583

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  25 in total

1.  Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues.

Authors:  Beatrice S Knudsen; April N Allen; Dale F McLerran; Robert L Vessella; Jonathan Karademos; Joan E Davies; Botoul Maqsodi; Gary K McMaster; Alan R Kristal
Journal:  J Mol Diagn       Date:  2008-02-14       Impact factor: 5.568

2.  Laboratory procedures to generate viral metagenomes.

Authors:  Rebecca V Thurber; Matthew Haynes; Mya Breitbart; Linda Wegley; Forest Rohwer
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Viral metagenomics: a tool for virus discovery and diversity in aquaculture.

Authors:  S V Alavandi; M Poornima
Journal:  Indian J Virol       Date:  2012-08-14

4.  Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.

Authors:  Bharathi Laxman; Scott A Tomlins; Rohit Mehra; David S Morris; Lei Wang; Beth E Helgeson; Rajal B Shah; Mark A Rubin; John T Wei; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

5.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

Review 6.  A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium.

Authors:  Chris Mullins; M Scott Lucia; Simon W Hayward; Jeannette Y Lee; Jonathan M Levitt; Victor K Lin; Brian C-S Liu; Arul M Chinnaiyan; Mark A Rubin; Kevin Slawin; Robert A Star; Robert H Getzenberg
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

7.  Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples.

Authors:  Craig April; Brandy Klotzle; Thomas Royce; Eliza Wickham-Garcia; Tanya Boyaniwsky; John Izzo; Donald Cox; Wendell Jones; Renee Rubio; Kristina Holton; Ursula Matulonis; John Quackenbush; Jian-Bing Fan
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

8.  Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.

Authors:  Jennifer L Gregg; Kathleen E Brown; Eric M Mintz; Helen Piontkivska; Gail C Fraizer
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

9.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

10.  Transcriptomic and genetic analysis of direct interspecies electron transfer.

Authors:  Pravin Malla Shrestha; Amelia-Elena Rotaru; Zarath M Summers; Minita Shrestha; Fanghua Liu; Derek R Lovley
Journal:  Appl Environ Microbiol       Date:  2013-02-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.